Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.
Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Thomas Szekeres(Medical University of Vienna), Michael Grusch(Comprehensive Cancer Center Vienna), Mike Harik, Sybille Marihart-Fazekas, Thomas Erker(University of Vienna), Bob Djavan, Norbert Handler(University of Vienna), Mehmet Özsüy, Philipp Saiko(Ludwig Boltzmann Institute Applied Diagnostics), Monika Fritzer‐Szekeres(Vienna General Hospital), Walter Jaeger(University of Vienna)
PubMed
November 27, 2007
Cited by 43
Related Papers
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship
|Biochemical Pharmacology|2005|303